1. Home
  2. REGN
  3. REGN News

Latest Regeneron Pharmaceuticals Inc. (REGN) News on June 1, 2025

This week in Trumponomics: Too bad TACO isn’t true
REGN

Yahoo Finance

13 hours ago

This week in Trumponomics: Too bad TACO isn’t true

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
REGN

Yahoo Finance Video

13 hours ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Ford recalls more than 29,000 vehicles in the US, NHTSA says
REGN

Reuters

13 hours ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states
REGN

USA TODAY

13 hours ago

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

Saturday Sessions: OK Go performs "Love"
REGN

CBS News Videos

13 hours ago

Saturday Sessions: OK Go performs "Love"

Behind the scenes of an OK Go music video
REGN

CBS News Videos

13 hours ago

Behind the scenes of an OK Go music video

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital
REGN

Simply Wall St.

13 hours ago

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back
REGN

Investor's Business Daily

13 hours ago

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance
REGN

GuruFocus.com

2 days ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

Swiss officials halt further evacuations after glacier collapse
REGN

AFP

2 days ago

Swiss officials halt further evacuations after glacier collapse

Family RV Association Announces Dates For Future National Rallies
REGN

PR Newswire

2 days ago

Family RV Association Announces Dates For Future National Rallies

Semiconductor Gas Abatement Systems Market Poised to Reach USD 5.8 Billion by 2034 | Exactitude Consultancy
REGN

GlobeNewswire

2 days ago

Semiconductor Gas Abatement Systems Market Poised to Reach USD 5.8 Billion by 2034 | Exactitude Consultancy

Government of Canada to build new research facility to improve transportation safety
REGN

CNW Group

2 days ago

Government of Canada to build new research facility to improve transportation safety

GlobeMed Saudi ties up with Orient Insurance to offer healthcare services
REGN

Life Insurance International

2 days ago

GlobeMed Saudi ties up with Orient Insurance to offer healthcare services

Dow Jones Falls As Trump Says China 'Violated' Agreement; Tesla Tests Buy Point
REGN

Investor's Business Daily

2 days ago

Dow Jones Falls As Trump Says China 'Violated' Agreement; Tesla Tests Buy Point

Awfully Posh relaunches peanut range with 100% recyclable paper wrapper
REGN

Packaging Gateway

2 days ago

Awfully Posh relaunches peanut range with 100% recyclable paper wrapper

The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
REGN

Motley Fool

3 days ago

The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.

Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency
REGN

Insider Monkey

3 days ago

Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency

Heart Disease Could Be a Goner When These New Drugs Arrive
REGN

Barrons.com

3 days ago

Heart Disease Could Be a Goner When These New Drugs Arrive

Regeneron Pharmaceuticals (NasdaqGS:REGN) Adopts Innovative Technology for Faster Drug Discovery
REGN

Simply Wall St.

3 days ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) Adopts Innovative Technology for Faster Drug Discovery

REGN

MT Newswires

4 days ago

Regeneron Pharmaceuticals' True Value Masked by Eylea Concerns, RBC Says

3 Value Stocks with Questionable Fundamentals
REGN

StockStory

5 days ago

3 Value Stocks with Questionable Fundamentals

Does the 23andMe Acquisition Make Regeneron a Buy Now?
REGN

Motley Fool

8 days ago

Does the 23andMe Acquisition Make Regeneron a Buy Now?

Regeneron announces initial results from two cohorts of LINKER-MM2 trial
REGN

TipRanks

8 days ago

Regeneron announces initial results from two cohorts of LINKER-MM2 trial

Regeneron Initial Data on Multiple Myeloma Drug Encouraging
REGN

Zacks

8 days ago

Regeneron Initial Data on Multiple Myeloma Drug Encouraging

Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication
REGN

Zacks

8 days ago

Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication

Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports Promising Results In LINKER-MM2 Trial For Linvoseltamab
REGN

Simply Wall St.

8 days ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports Promising Results In LINKER-MM2 Trial For Linvoseltamab

Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.
REGN

Barrons.com

9 days ago

Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.

REGN

MT Newswires

9 days ago

Regeneron Pharmaceuticals Reveals Trial Data of Drug Combination to Treat Multiple Myeloma

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
REGN

GlobeNewswire

9 days ago

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Made A “Very Smart Deal,” Says Jim Cramer
REGN

Insider Monkey

10 days ago

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Made A “Very Smart Deal,” Says Jim Cramer

Viz.ai, Sanofi and Regeneron to link for COPD management
REGN

Pharmaceutical Technology

10 days ago

Viz.ai, Sanofi and Regeneron to link for COPD management

REGN

Argus Research

11 days ago

Technical Assessment: Bullish in the Intermediate-Term

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
REGN

Benzinga

11 days ago

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

3 Cash-Producing Stocks in Hot Water
REGN

StockStory

11 days ago

3 Cash-Producing Stocks in Hot Water

S&P 500 Gains and Losses Today: FICO Stock Falls as Federal Housing Official Questions Pricing
REGN

Investopedia

11 days ago

S&P 500 Gains and Losses Today: FICO Stock Falls as Federal Housing Official Questions Pricing

Regeneron Pharmaceuticals (NasdaqGS:REGN) Partners With Viz.ai For AI-Powered COPD Solutions
REGN

Simply Wall St.

11 days ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) Partners With Viz.ai For AI-Powered COPD Solutions

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care
REGN

Pharmaceutical Technology

11 days ago

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care

Evercore says 23andMe buyout removes downside case for OraSure
REGN

TipRanks

11 days ago

Evercore says 23andMe buyout removes downside case for OraSure

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research
REGN

Zacks

12 days ago

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research

1 Nasdaq 100 Stock with Exciting Potential and 2 to Think Twice About
REGN

StockStory

16 days ago

1 Nasdaq 100 Stock with Exciting Potential and 2 to Think Twice About

REGN

MT Newswires

16 days ago

Regeneron Pharmaceuticals Wins $406.8 Million Antirust Verdict Against Amgen

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
REGN

GlobeNewswire

16 days ago

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

Regeneron Upgraded as AbbVie Catches Policy Heat
REGN

GuruFocus.com

17 days ago

Regeneron Upgraded as AbbVie Catches Policy Heat

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
REGN

Barrons.com

18 days ago

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.

REGN

MT Newswires

18 days ago

Citigroup Upgrades Regeneron Pharmaceuticals to Buy From Neutral, Adjusts PT to $700 From $600

REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion
REGN

StockStory

19 days ago

REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion

REGN

MT Newswires

20 days ago

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $896 From $979, Maintains Outperform Rating

3 of Wall Street’s Favorite Stocks Skating on Thin Ice
REGN

StockStory

20 days ago

3 of Wall Street’s Favorite Stocks Skating on Thin Ice

Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports Q1 2025 Revenue Drop to US$3,029 Million
REGN

Simply Wall St.

21 days ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports Q1 2025 Revenue Drop to US$3,029 Million

Is Regeneron Pharmaceuticals, Inc. (REGN) the Worst Blue Chip Stock to Buy?
REGN

Insider Monkey

21 days ago

Is Regeneron Pharmaceuticals, Inc. (REGN) the Worst Blue Chip Stock to Buy?

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Numbers Came Up A Little Short’
REGN

Insider Monkey

22 days ago

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Numbers Came Up A Little Short’

1 Cash-Heavy Stock on Our Buy List and 2 to Ignore
REGN

StockStory

23 days ago

1 Cash-Heavy Stock on Our Buy List and 2 to Ignore

Regeneron Pharmaceuticals, Inc. (REGN): Among the Cheap ESG Stocks to Buy According to Hedge Funds
REGN

Insider Monkey

24 days ago

Regeneron Pharmaceuticals, Inc. (REGN): Among the Cheap ESG Stocks to Buy According to Hedge Funds

Regeneron Pharmaceuticals (REGN): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential
REGN

Insider Monkey

25 days ago

Regeneron Pharmaceuticals (REGN): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y
REGN

Zacks

a month ago

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’
REGN

Insider Monkey

a month ago

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’

Regeneron Pharmaceuticals (NasdaqGS:REGN) To Showcase Oncology And Respiratory Data At Major Conferences
REGN

Simply Wall St.

a month ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) To Showcase Oncology And Respiratory Data At Major Conferences

Regeneron price target lowered to $940 from $975 at Truist
REGN

TipRanks

a month ago

Regeneron price target lowered to $940 from $975 at Truist

Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
REGN

GlobeNewswire

a month ago

Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination

Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
REGN

GlobeNewswire

a month ago

Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases

REGN

MT Newswires

a month ago

Guggenheim Cuts Regeneron Pharmaceuticals' Price Target to $810 From $940

REGN

Morningstar Research

a month ago

Analyst Report: Regeneron Pharmaceuticals, Inc.

REGN

MT Newswires

a month ago

Goldman Cuts Regeneron Pharmaceuticals' Price Target to $804 From $917

REGN

MT Newswires

a month ago

BMO Cuts Regeneron Pharmaceuticals' Price Target to $800 From $865

REGN

MT Newswires

a month ago

Evercore ISI Cuts Regeneron Pharmaceuticals' Price Target to $900 From $950

REGN

MT Newswires

a month ago

Leerink Partners Cuts Regeneron Pharmaceuticals' Price Target to $686 From $780

REGN

MT Newswires

a month ago

RBC Cuts Price Target on Regeneron Pharmaceuticals to $943 From $1,051, Keeps Outperform Rating

Regeneron Pharmaceuticals First Quarter 2025 Earnings: Revenues Disappoint
REGN

Simply Wall St.

a month ago

Regeneron Pharmaceuticals First Quarter 2025 Earnings: Revenues Disappoint

REGN

MT Newswires

a month ago

Truist Cuts Price Target on Regeneron Pharmaceuticals to $940 From $975, Keeps Buy Rating

Regeneron Pharmaceuticals Inc (REGN) Q1 2025 Earnings Call Highlights: Strong Dupixent Sales ...
REGN

GuruFocus.com

a month ago

Regeneron Pharmaceuticals Inc (REGN) Q1 2025 Earnings Call Highlights: Strong Dupixent Sales ...

REGN

Thomson Reuters StreetEvents

a month ago

Q1 2025 Regeneron Pharmaceuticals Inc Earnings Call

Regeneron Crashes 7% After Eylea Miss Drags Its Earnings Down
REGN

Investor's Business Daily

a month ago

Regeneron Crashes 7% After Eylea Miss Drags Its Earnings Down

REGN

MT Newswires

a month ago

Equity Markets Higher Despite Weak US Consumer Confidence Data

Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
REGN

Benzinga

a month ago

Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides

Regeneron Crashes 10% After Eylea Miss Drags Its Earnings Report
REGN

Investor's Business Daily

a month ago

Regeneron Crashes 10% After Eylea Miss Drags Its Earnings Report

REGN

MT Newswires

a month ago

Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday

Regeneron Stock Plummets After Earnings Miss
REGN

Barrons.com

a month ago

Regeneron Stock Plummets After Earnings Miss

Regeneron Pharma's first-quarter results miss on lower Eylea demand
REGN

Reuters

a month ago

Regeneron Pharma's first-quarter results miss on lower Eylea demand

Regeneron (REGN) Lags Q1 Earnings and Revenue Estimates
REGN

Zacks

a month ago

Regeneron (REGN) Lags Q1 Earnings and Revenue Estimates

REGN

Associated Press Finance

a month ago

Regeneron: Q1 Earnings Snapshot

Regeneron (NASDAQ:REGN) Misses Q1 Sales Targets
REGN

StockStory

a month ago

Regeneron (NASDAQ:REGN) Misses Q1 Sales Targets

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals' Q1 Adjusted Earnings, Revenue Fall

REGN

MT Newswires

a month ago

Regeneron Pharmaceuticals' Lynozyfic Receives Conditional Approval in Europe for Multiple Myeloma

Regeneron expands US manufacturing with $3B Fujifilm partnership
REGN

Manufacturing Dive

a month ago

Regeneron expands US manufacturing with $3B Fujifilm partnership

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
REGN

GlobeNewswire

a month ago

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
REGN

GlobeNewswire

a month ago

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

Regeneron (REGN) Reports Earnings Tomorrow: What To Expect
REGN

StockStory

a month ago

Regeneron (REGN) Reports Earnings Tomorrow: What To Expect

Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
REGN

Motley Fool

a month ago

Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold

REGN

MT Newswires

a month ago

Evercore ISI Adjusts Regeneron Pharmaceuticals PT to $950 From $1,000, Maintains Outperform Rating

REGN

MT Newswires

a month ago

Baird Cuts Price Target on Regeneron Pharmaceuticals to $652 From $759

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
REGN

Zacks

a month ago

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings
REGN

Zacks

a month ago

What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More
REGN

Zacks

a month ago

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

REGN

MT Newswires

a month ago

Truist Adjusts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Maintains Buy Rating

REGN

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $970, Maintains Buy Rating

REGN

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $900, Maintains Overweight Rating

REGN

MT Newswires

a month ago

Truist Cuts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Keeps Buy Rating

Regeneron to Report Q1 Earnings: What's in Store for the Stock?
REGN

Zacks

a month ago

Regeneron to Report Q1 Earnings: What's in Store for the Stock?

Regeneron Pharmaceuticals (NasdaqGS:REGN) Expands U.S. Capacity With US$3 Billion Fujifilm Partnership
REGN

Simply Wall St.

a month ago

Regeneron Pharmaceuticals (NasdaqGS:REGN) Expands U.S. Capacity With US$3 Billion Fujifilm Partnership

Share on Social Networks: